Stelara® Effective Over One Year and Reduces Severe Flares
Results of two analyses from a Phase 2 study of Stelara® (ustekinumab) in lupus showed the drug’s effectiveness over...
News
Rituximab Effective for Maintenance Lupus Treatment Shows Study
June 13, 2019
A study published in Arthritis & Rheumatology found that rituximab was helpful as a maintenance therapy for...
VALUE Study Results Reported at EULAR
MADRID, Spain. June 13, 2019 – Results of the first clinical trial conducted through the Lupus Research Alliance Lupus...
Results Presented at EULAR Find Investigational Lupus Treatment NKTR-358 Safe
June 13, 2019
New results from a clinical study with healthy volunteers found the investigational compound NKTR-358 safe and well-tolerated,...
Making Good Immune System Cells Turn Bad
Normally helpful immune system cells become harmful in patients with lupus. With a Novel Research Grant from the LRA,...
Lupus Research Alliance Pleased to Share Positive News about Potential Drug for Lupus Nephritis
NEW YORK, NY. June 11, 2019. The Lupus Research Alliance is pleased to share positive topline results from a...
Lupus Counts as a National Men’s Health Issue
June is National Men’s Health Month, when the Lupus Research Alliance works to raise awareness of lupus as a...
Anti-Nuclear Antibodies May Confuse Lupus Diagnosis
Patients who may have lupus typically undergo an “ANA” test to detect anti-nuclear antibodies (ANAs). Lupus Research Alliance Distinguished...
New Study Partly Funded by LRA Reveals Novel Lupus Drug Targets
NEW YORK, NY – May 29. Researchers partly funded by the Lupus Research Alliance (LRA) have found possible new...
Discovering Lupus Heterogeneity
May 22, 2019
Lupus is heterogeneous, meaning that symptoms are many and vary widely from patient to patient -- one...
LRA Researchers Reveal New Drug Targets at Leading Immunology Conference
May 22, 2019
Data presented by several Lupus Research Alliance-funded scientists at the recent American Association of Immunologists Annual Meeting...
Your Advocacy Works –House Appropriations Bill Includes $10 M for Lupus Research Program
May 21, 2019
The U.S. House of Representatives Appropriations Committee today passed the Defense Appropriations bill, which allocates our full...